The Monetary, Clinical and Ethical Value of Patient Data – A View from the UK and NHS
Health Populi
JULY 23, 2019
. “Unlocking the insights contained in patient genomic and phenotypic data is of high value to all the key stakeholders in the health care ecosystem: patients, providers, payers and the life sciences sector,” EY introduces the report. What’s not CGD are data covered by HIPAA. The reality of U.S. In the U.S.,
149 
Let's personalize your content